Emerging engineered magnetic nanoparticulate probes for molecular MRI of atherosclerosis: how far have we come?

Area of Science:

• Cardiovascular Medicine
• Immunology
• Radiology

Background:

• Atherosclerosis is a silent, progressive inflammatory disease of arteries, leading to major cardiovascular events like heart attack and stroke.
• Current diagnostic challenges include the need for safe, noninvasive, and accurate methods to identify high-risk vulnerable plaques before catastrophic events.
• Understanding the molecular pathogenesis of atherosclerosis is crucial for developing advanced diagnostic tools.

Purpose of the Study:

• To review the molecular pathogenesis of atherosclerosis.
• To explore advancements in molecular magnetic resonance imaging (MRI) for atherosclerosis detection.
• To highlight the potential of novel nanoparticulate probes for identifying vulnerable plaques.

Main Methods:

• Review of current literature on atherosclerosis pathogenesis.
• Discussion of molecular MRI techniques and engineered magnetic nanoparticulate probes.
• Focus on probes targeting molecular and cellular players in early lesion to plaque rupture.

Main Results:

• Recent understanding of molecular pathogenesis provides new targets for diagnosis.
• Engineered magnetic nanoparticulate probes show potential for molecular MRI.
• These probes can target key processes like inflammation, angiogenesis, and apoptosis in vulnerable plaques.

Conclusions:

• Molecular MRI with targeted nanoparticles offers a promising noninvasive approach for early detection of high-risk atherosclerotic plaques.
• This technology could enable timely intervention to prevent major cardiovascular events.
• Further development and validation of these probes are essential for clinical application.